What's Happening?
Piramal Pharma Solutions has acquired a Korsch XM-12 bilayer tablet press for its Morpeth, UK facility. This addition enhances the company's formulation capabilities, allowing for the development of fixed dose combinations and modified release drug delivery. The new equipment supports both single-layer and bilayer production, offering greater precision and efficiency in tablet manufacturing.
Why It's Important?
The acquisition of the Korsch XM-12 tablet press demonstrates Piramal Pharma Solutions' commitment to advancing drug delivery technologies. By enhancing its formulation capabilities, the company can better serve its clients and contribute to the development of innovative therapies. This investment also highlights the importance of continuous improvement and quality in pharmaceutical manufacturing.
What's Next?
Piramal Pharma Solutions plans to implement comprehensive training protocols to ensure the safe and effective use of the new equipment. The company will continue to focus on delivering high-quality drug products and expanding its capabilities to meet the evolving needs of the pharmaceutical industry.
